Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-16

Clinical Trial Update: Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating the transplantation of fetal retinal pigment epithelium cells for age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fetal retinal pigment epithelium cell transplantation

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Age Related Macular Degeneration, Macular Degeneration | EARLY_Phase 1 | Status: UNKNOWN